Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-13-010170
Filing Date
2013-06-11
Accepted
2013-06-11 21:04:34
Documents
1
Period of Report
2013-06-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 22741
  Complete submission text file 0001179110-13-010170.txt   24107
Mailing Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 650-266-0000
ONYX PHARMACEUTICALS INC (Issuer) CIK: 0001012140 (see all company filings)

EIN.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ZYMOGENETICS, INC. 1201 EASTLAKE AVENUE SEATTLE WA 98102
Business Address
SHEMA SUZANNE M (Reporting) CIK: 0001225509 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-28298 | Film No.: 13907540